Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)
China flag China · Delayed Price · Currency is CNY
14.16
+0.10 (0.71%)
Apr 28, 2026, 3:04 PM CST

SHE:300601 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
169.31257.3432.841,1961,0183,550
Short-Term Investments
-715.972,174463.34531.58725.57
Trading Asset Securities
1,7111,689-100.02440.83-
Cash & Short-Term Investments
1,8812,6622,6071,7591,9904,275
Cash Growth
755.12%2.12%48.21%-11.61%-53.45%40.73%
Accounts Receivable
2,7522,5842,7872,7882,2931,858
Other Receivables
11.4311.1610.548.911.3814.25
Receivables
2,7642,5952,7982,7972,3051,872
Inventory
693.73681.09782.77772.85727.81,058
Other Current Assets
618.2856.6655.0967.51152.34135.14
Total Current Assets
5,9575,9956,2425,3965,1757,341
Property, Plant & Equipment
4,8684,9655,2255,7165,1764,116
Long-Term Investments
00-311.68302.38105.64
Other Intangible Assets
497.26467.9436.66433.45357.98346.04
Long-Term Deferred Tax Assets
683.15689.49697.63630.32708.32558.6
Long-Term Deferred Charges
277.99299.2268.26172.47195.95489.6
Other Long-Term Assets
1,7031,6791,6932,4251,8711,192
Total Assets
13,98614,09514,56415,08513,78614,149
Accounts Payable
571.06708.25847.83882.48434.13708.2
Accrued Expenses
54.071,2801,3581,5951,330807.26
Short-Term Debt
11.01-34.160.04170.07777.53
Current Portion of Long-Term Debt
25.5316.66202.9532.32103.6122.6
Current Income Taxes Payable
17.62-6.32--65.64
Current Unearned Revenue
24.640.8619.2828.7631.2394.51
Other Current Liabilities
1,371169.68178.17152.69270.96142.39
Total Current Liabilities
2,0752,2162,6472,7512,3402,618
Long-Term Debt
1,8901,8701,7862,3722,0161,938
Long-Term Unearned Revenue
258.3262.21247.82328.7383.1349.54
Long-Term Deferred Tax Liabilities
0.670.6734.5226.8926.0841.47
Other Long-Term Liabilities
97.1115.42186.7264.5136.3335.13
Total Liabilities
4,3214,4644,9035,5444,8014,982
Common Stock
1,1171,1171,1171,1171,120687.09
Additional Paid-In Capital
5,5125,5125,5115,3695,4905,357
Retained Earnings
2,5262,4922,5232,5441,8842,612
Treasury Stock
-----20-0.55
Comprehensive Income & Other
510.79510.83510.95511.1511.14511.3
Total Common Equity
9,6659,6329,6619,5428,9859,167
Minority Interest
0.11-0.16-0.1---
Shareholders' Equity
9,6659,6329,6619,5428,9859,167
Total Liabilities & Equity
13,98614,09514,56415,08513,78614,149
Total Debt
1,9271,8872,0242,4652,2892,738
Net Cash (Debt)
-46.13775.57583.32-705.64-299.341,537
Net Cash Growth
-32.96%----47.84%
Net Cash Per Share
-0.040.660.52-0.63-0.271.38
Filing Date Shares Outstanding
1,1171,1171,1171,1171,1201,120
Total Common Shares Outstanding
1,1171,1171,1171,1171,1201,099
Working Capital
3,8823,7793,5952,6452,8354,723
Book Value Per Share
8.658.628.658.548.028.34
Tangible Book Value
9,1689,1649,2249,1088,6278,821
Tangible Book Value Per Share
8.218.208.268.157.708.02
Buildings
-2,7512,7802,7181,037939.37
Machinery
-3,1852,8401,8531,6711,682
Construction In Progress
-711.43990.282,2813,4632,320
Source: S&P Global Market Intelligence. Standard template. Financial Sources.